QCM
PVLA

Quantinno Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Quantinno Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+1,517
New +$184K ﹤0.01% 3301

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Quantinno Capital Management's PVLA Position: Q2 2026 in Review

Quantinno Capital Management opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 1,517 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #3301 among its holdings.

197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Quantinno Capital Management held 1,517 shares of Palvella Therapeutics worth $232K as of Q2 2026.
  • Palvella Therapeutics was a new Quantinno Capital Management position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3301 holding.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.